Want to see TSE:JWEL full AI Analyst Report?
JWEL Stock Chart & Stats
C$40.87
C$1.31(3.21%)
At close: 4:00 PM EDT
C$40.87
C$1.31(3.21%)
Day’s Range― - ―
52-Week RangeC$32.54 - C$43.00
Previous CloseN/A
Volume45.95K
Average Volume (3M)59.01K
Market Cap
C$1.72B
Enterprise ValueC$1.94K
Total Cash (Recent Filing)C$39.86M
Total Debt (Recent Filing)C$475.87M
Price to Earnings (P/E)23.5
Beta0.78
Next Earnings
Aug 06, 2026EPS Estimate
0.41Next Dividend Ex-DateN/A
Dividend Yield2.22%
Share Statistics
EPS (TTM)1.76
Shares Outstanding41,481,953
10 Day Avg. Volume47,826
30 Day Avg. Volume59,011
Financial Highlights & Ratios
PEG Ratio1.18
Price to Book (P/B)2.90
Price to Sales (P/S)1.71
P/FCF Ratio20.17
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$46.50Price Target Upside13.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)2.14
Revenue Forecast (FY)C$918.98M
Bulls Say, Bears Say
Bulls Say
Branded Portfolio & DistributionJamieson's entrenched Jamieson brand and multi-channel, multi-country distribution provide durable revenue resilience. Strong shelf presence with retail, pharmacy and other consumer channels supports repeat purchases and defendable market share versus private labels over the coming 2–6 months.
Strong Profitability MarginsSustained high gross and healthy operating margins signal structural cost efficiency and pricing power in its VMS business. These margins fund R&D, marketing and manufacturing investments, support steady ROE and provide cushion versus modest top-line volatility over the medium term.
Consistent Top-line GrowthModest but consistent revenue growth indicates underlying demand stability and steady market penetration. A multi-year growth trend reduces execution risk for near-term plans and supports scale benefits in manufacturing and distribution over the next several quarters.
Bears Say
Weak Cash GenerationA sharp fall in operating cash flow and a ~54% drop in free cash flow materially erode financial flexibility. This weak cash conversion raises risk for funding capex, working capital and dividends, and increases reliance on external financing during downturns over the medium term.
Meaningful LeverageDebt roughly equal to equity reduces balance-sheet flexibility and increases interest and refinancing exposure. With leverage elevated, earnings or cash-flow hiccups could constrain capital allocation and make the company more sensitive to rate moves and credit conditions over the next several quarters.
Margin Compression RiskObserved margin compression versus prior years suggests structural cost inflation or adverse product mix. Continued pressure could erode the current profitability buffer and limit reinvestment capacity, making earnings more vulnerable if pricing power weakens in the medium term.
Jamieson Wellness Inc News
JWEL FAQ
What was Jamieson Wellness Inc’s price range in the past 12 months?
Jamieson Wellness Inc lowest stock price was C$32.54 and its highest was C$43.00 in the past 12 months.
What is Jamieson Wellness Inc’s market cap?
Jamieson Wellness Inc’s market cap is C$1.72B.
When is Jamieson Wellness Inc’s upcoming earnings report date?
Jamieson Wellness Inc’s upcoming earnings report date is Aug 06, 2026 which is tomorrow.
How were Jamieson Wellness Inc’s earnings last quarter?
Jamieson Wellness Inc released its earnings results on May 07, 2026. The company reported C$0.17 earnings per share for the quarter, beating the consensus estimate of C$0.135 by C$0.035.
Is Jamieson Wellness Inc overvalued?
According to Wall Street analysts Jamieson Wellness Inc’s price is currently Undervalued.
Does Jamieson Wellness Inc pay dividends?
Jamieson Wellness Inc pays a Quarterly dividend of C$0.23 which represents an annual dividend yield of 2.22%. See more information on Jamieson Wellness Inc dividends here
What is Jamieson Wellness Inc’s EPS estimate?
Jamieson Wellness Inc’s EPS estimate is 0.41.
How many shares outstanding does Jamieson Wellness Inc have?
Jamieson Wellness Inc has 41,481,953 shares outstanding.
What happened to Jamieson Wellness Inc’s price movement after its last earnings report?
Jamieson Wellness Inc reported an EPS of C$0.17 in its last earnings report, beating expectations of C$0.135. Following the earnings report the stock price went up 3.773%.
Which hedge fund is a major shareholder of Jamieson Wellness Inc?
Currently, no hedge funds are holding shares in TSE:JWEL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Jamieson Wellness Inc Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-0.12%
12-Months-Change
Fundamentals
Return on Equity
2.22%
Trailing 12-Months
Asset Growth
6.13%
Trailing 12-Months
Company Description
Jamieson Wellness Inc
Jamieson Wellness Inc. is a natural health products company involved in the development, manufacturing, marketing, and distribution of its offerings across Canada and internationally. The enterprise operates through two core segments. Its Jamieson Brands division focuses on human health products such as vitamins, herbal and mineral nutritional supplements, and over-the-counter remedies, marketed under the Jamieson and Lorna Vanderhaeghe labels. This segment also includes sports nutrition products sold under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides product development and manufacturing services on a contract basis to notable consumer health businesses and retailers. Jamieson Wellness Inc. reaches its customers through distributors, as well as retail and wholesale channels. Founded in 1922, the company, which adopted its current name in May 2017 after previously being known as Jamieson Intermediate Holdings Ltd., is based in Toronto, Canada.
JWEL Stock 12 Month Forecast
Average Price Target
C$46.50
▲(13.78% Upside)